Silence Therapeutics plc ( SLN) - Stock Earnings
SLN Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
SLN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -11.8 million USD | 34000 USD |
| 2026Q1 | -14.9 million USD | 421292 USD |
| 2026Q2 | -12.3 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
SLN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -43.3 million USD | 25.4 million USD |
| 2024 | -45.3 million USD | 43.3 million USD |
| 2025 | -88.6 million USD | 559000 USD |
| 2026 Est. | — | — |
SLN
Price: $9.83
52 week price:
Earnings Per Share: -1.19 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United Kingdom
Volume: 18800
Market Capitalization: 698.6 million